STOCKHOLM, SWEDEN November 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has received regulatory approval to initiate the ...

Skin conditions, diet choices, and some chronic health conditions may make the bottom of your feet yellow. Treating the cause ...

New York-Presbyterian filed plans Thursday to construct a new oncology infusion suite at its Queens hospital, becoming the ...

The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...

Ascentage Pharma Group International (($HK:6855)) announced an update on their ongoing clinical study. Study Overview: Ascentage Pharma Group Inc.

Disc Medicine, Inc. (($IRON)) announced an update on their ongoing clinical study. Disc Medicine, Inc. is conducting a study titled RALLY-MF: A ...

Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.

wait weeks for showers There isn't a cure for warm autoimmune hemolytic anemia, so Davis likely will have regular blood tests ...

Patients with myelofibrosis and anemia showed similar spleen size and symptom improvements as the overall JUMP study cohort when treated with ESAs or danazol and Jakafi. The JUMP trial, a phase 3b ...